Eugene Sefanov

  Most of us “regular people” refer to pharmaceutical products by their trade name, but that’s not the case among life sciences professionals in research and development departments. In fact, during a product’s lifecycle, chances are it has been referred to by at least four names: a chemical compound, a company code, a generic name, […]

  While 6 medical device companies and 11 pharmaceutical organizations made the cut for this year’s Fortune 500 list, Quintiles (#476) was the only contract research organization (CRO) to make an appearance. With over $4 billion in revenue in 2014, this is Quintiles’ second year on the list. To see which pharma and biotech companies […]

  Eleven pharma and biotech companies appeared on this year’s Fortune 500 list. While there are additional organizations (e.g., Procter & Gamble) that manufacturer medicines on the list, they weren’t classified as pharmaceutical companies in the ranking. These are the drug companies that made this year’s list, ranked by total annual revenue: 

  Wow, it’s not often you hear about executives from life sciences companies getting jail time. But in the case of the former CEO of OtisMed, that’s just what he got: two years and a small fine. The company also agreed to pay more than $80 million to resolve other charges. Without receiving FDA approval, […]

Photo Credit: Maglara / Shutterstock.com My colleague, Beth Martin, wrote a great blog post today about the benefits of using Google Search for Work. What is Google Search for Work, you ask? Think of it as using Google to search the Internet, except that you search your company’s systems instead. Take a look at the infographic below, which […]

  Now that July is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in June – they’re ranked in order of popularity, with number one being the most viewed piece. 

  2015 marks the 61st release of the Fortune 500 list. And while many of the same companies continue to make their annual appearance, we do see new names added to the list and some removed. For example, Medtronic did not make this year’s list, since it recently moved its headquarters to Ireland (companies have […]

  CIO, a leading news source published by IDG Enterprise and geared towards IT leaders, announced their list of the top 100 companies who “have distinguished themselves by creating business value through the innovative use of technology.” The magazine also selected five CIOs for the 2015 Hall of Fame. One of the five happens to […]

  The Merck Manual, first published in 1899 and one of the most widely used and comprehensive set of medical resources for professionals and consumers, has finally decided to stop printing paper versions of the book. Editor-in-Chief of The Merck Manual, Dr. Robert S. Porter, summed up their motivation for the transition nicely: “There will […]

  On June, 28, 2015, CNN will be presenting Glen Campbell: I’ll Be Me, a documentary that showcases the life of the award-winning musician who struggles with Alzheimer’s. What’s unique about the film’s presentation, aside from the story itself, is that it will be complemented with three targeted commercials: a 30-second commercial, in which Eli […]

  Coinciding with the Drug Information Association’s (DIA) 51st Annual Meeting in Washington, D.C. last week, Oracle announced the newest version of its drug safety and pharmacovigilance system. Argus Safety 8.0, considered a major release, offers new features and functionality to help life sciences companies comply with ever-changing global regulatory requirements. The Standard Edition of […]

  After sitting through a week’s worth of presentations and case studies related to digital transformation, I can’t help but think about the deep changes AstraZeneca has gone through in recent years. It’s been a massive feat with extraordinary outcomes, and they’re still not done making positive changes throughout their operations. AstraZeneca’s goal was to […]